A Randomised, Open-Label, Active-Controlled, Parallel Group, Single-Centre, 4-Week Study to Evaluate the Safety of High Dose Budesonide after Multiple Dosing with Investigational HFA Metered Dose Inhaler and Conventional CFC Metered Dose Inhaler (Pulmicort) in Healthy Subjects.
Study identifier:D5252C00004
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Randomised, Open-Label, Active-Controlled, Parallel Group, Single-Centre, 4-Week Study to Evaluate the Safety of High Dose Budesonide after Multiple Dosing with Investigational HFA Metered Dose Inhaler and Conventional CFC Metered Dose Inhaler (Pulmicort) in Healthy Subjects.
Medical condition
asthma
Phase
Phase 1
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Feb 2004
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
